Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield
26 May 2020

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

UK EXECUTIVE CHANGE SUMMARY: New Chairs For Matomy And Shield

Shield Therapeutics names Hans Peter Hasler as next chairman
26 May 2020

Shield Therapeutics names Hans Peter Hasler as next chairman

(Sharecast News) - Pharmaceutical group Shield Therapeutics named Hans Peter Hasler as non-executive chairman of the company on Tuesday.

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests
1 May 2020

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

UK TRADING UPDATE SUMMARY: Avacta, Genedrive Progress With Virus Tests

Shield Therapeutics FY revenues impacted by milestone repayment
1 May 2020

Shield Therapeutics FY revenues impacted by milestone repayment

(Sharecast News) - Pharmaceuticals outfit Shield Therapeutics warned on Friday that full-year revenues would be lower than originally anticipated afte...

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder
22 Apr 2020

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

UK EXECUTIVE CHANGE SUMMARY: Shield Therapeutics Replaces Founder

Shield Therapeutics Starts Independent Review Into Feraccru Study
18 Mar 2020

Shield Therapeutics Starts Independent Review Into Feraccru Study

Shield Therapeutics Starts Independent Review Into Feraccru Study

Shield launches review after spotting flaw in 'Feraccru' study
17 Mar 2020

Shield launches review after spotting flaw in 'Feraccru' study

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on the 'AEGIS-H2H' clinical trial on Tuesday, the da...

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations
27 Jan 2020

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations

Shield Therapeutics 2019 Revenue To Drop But Will Meet Expectations